Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Zfp385d | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZFP385D mRNA | CTD | PMID:32109520 | Zfp385d | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ZFP385D mRNA | CTD | PMID:32109520 | Zfp385d | Rat | 2-palmitoylglycerol | increases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of ZNF385D mRNA | CTD | PMID:37199045 | Zfp385d | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ZFP385D mRNA | CTD | PMID:23196670 | Zfp385d | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ZFP385D mRNA | CTD | PMID:24780913|PMID:30047161 | Zfp385d | Rat | all-trans-retinoic acid | decreases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of ZNF385D mRNA | CTD | PMID:23724009 | Zfp385d | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of ZFP385D mRNA | CTD | PMID:30047161 | Zfp385d | Rat | arsenite(3-) | decreases methylation | ISO | ZNF385D (Homo sapiens) | 6480464 | arsenite results in decreased methylation of ZNF385D promoter | CTD | PMID:23974009 | Zfp385d | Rat | arsenite(3-) | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to ZNF385D mRNA] | CTD | PMID:32406909 | Zfp385d | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of ZFP385D gene | CTD | PMID:28931070|PMID:35440735 | Zfp385d | Rat | benzo[a]pyrene | increases methylation | ISO | ZNF385D (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ZNF385D exon | CTD | PMID:27901495 | Zfp385d | Rat | benzo[a]pyrene | affects methylation | ISO | ZNF385D (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ZNF385D promoter | CTD | PMID:27901495 | Zfp385d | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ZFP385D mRNA; bisphenol A results in decreased expression more ... | CTD | PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998 | Zfp385d | Rat | bisphenol A | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ZNF385D gene | CTD | PMID:31601247 | Zfp385d | Rat | bisphenol A | increases methylation | ISO | ZNF385D (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of ZNF385D gene | CTD | PMID:31601247 | Zfp385d | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ZFP385D mRNA | CTD | PMID:33296240 | Zfp385d | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of ZFP385D mRNA | CTD | PMID:26033743 | Zfp385d | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of ZFP385D mRNA | CTD | PMID:26033743 | Zfp385d | Rat | cyclophosphamide | decreases expression | EXP | | 6480464 | Cyclophosphamide results in decreased expression of ZFP385D mRNA | CTD | PMID:27281708 | Zfp385d | Rat | dimethylselenide | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of more ... | CTD | PMID:33656867 | Zfp385d | Rat | dorsomorphin | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Zfp385d | Rat | doxorubicin | decreases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ZNF385D mRNA | CTD | PMID:29803840 | Zfp385d | Rat | entinostat | decreases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | entinostat results in decreased expression of ZNF385D mRNA | CTD | PMID:26272509 | Zfp385d | Rat | entinostat | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Zfp385d | Rat | fenofibrate | increases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | Fenofibrate results in increased expression of ZNF385D mRNA | CTD | PMID:25572481 | Zfp385d | Rat | fulvestrant | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ZNF385D gene | CTD | PMID:31601247 | Zfp385d | Rat | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of ZFP385D gene | CTD | PMID:35440735 | Zfp385d | Rat | mercury dibromide | decreases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of ZNF385D mRNA | CTD | PMID:26272509 | Zfp385d | Rat | mercury dibromide | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Zfp385d | Rat | methamphetamine | affects response to substance | ISO | ZNF385D (Homo sapiens) | 6480464 | ZNF385D gene SNP affects the susceptibility to Methamphetamine | CTD | PMID:18316681 | Zfp385d | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of ZFP385D mRNA | CTD | PMID:30047161 | Zfp385d | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of ZFP385D gene | CTD | PMID:35440735 | Zfp385d | Rat | methylmercury chloride | decreases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of ZNF385D mRNA | CTD | PMID:28001369 | Zfp385d | Rat | p-chloromercuribenzoic acid | decreases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of ZNF385D mRNA | CTD | PMID:26272509 | Zfp385d | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Zfp385d | Rat | panobinostat | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Zfp385d | Rat | panobinostat | decreases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | panobinostat results in decreased expression of ZNF385D mRNA | CTD | PMID:26272509 | Zfp385d | Rat | paracetamol | decreases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of ZNF385D mRNA | CTD | PMID:26690555|PMID:29067470 | Zfp385d | Rat | permethrin | increases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | Permethrin results in increased expression of ZNF385D mRNA | CTD | PMID:37047231 | Zfp385d | Rat | phenobarbital | affects expression | ISO | ZNF385D (Homo sapiens) | 6480464 | Phenobarbital affects the expression of ZNF385D mRNA | CTD | PMID:19159669 | Zfp385d | Rat | phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of ZFP385D mRNA | CTD | PMID:30047161 | Zfp385d | Rat | phenylmercury acetate | decreases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of ZNF385D mRNA | CTD | PMID:26272509 | Zfp385d | Rat | phenylmercury acetate | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Zfp385d | Rat | reactive oxygen species | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of more ... | CTD | PMID:33656867 | Zfp385d | Rat | SB 431542 | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Zfp385d | Rat | temozolomide | decreases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of ZNF385D mRNA | CTD | PMID:31758290 | Zfp385d | Rat | thapsigargin | increases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | Thapsigargin results in increased expression of ZNF385D mRNA | CTD | PMID:22378314 | Zfp385d | Rat | trichostatin A | decreases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ZNF385D mRNA | CTD | PMID:24935251|PMID:26272509 | Zfp385d | Rat | trichostatin A | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Zfp385d | Rat | valproic acid | affects expression | ISO | ZNF385D (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ZNF385D mRNA | CTD | PMID:25979313 | Zfp385d | Rat | valproic acid | multiple interactions | ISO | ZNF385D (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Zfp385d | Rat | valproic acid | decreases expression | ISO | ZNF385D (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ZNF385D mRNA | CTD | PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369 | Zfp385d | Rat | valproic acid | decreases methylation | ISO | ZNF385D (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of ZNF385D gene | CTD | PMID:29154799 | Zfp385d | Rat | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of ZFP385D mRNA | CTD | PMID:23034163 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















